本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Terns Pharmaceuticals, Inc.

7.25
+0.56008.37%
盘后7.24-0.0100-0.14%19:40 EDT
成交量:98.23万
成交额:699.18万
市值:6.34亿
市盈率:-6.96
高:7.26
开:6.70
低:6.70
收:6.69
52周最高:11.40
52周最低:1.87
股本:8,751.10万
流通股本:5,715.62万
量比:0.89
换手率:1.72%
股息:- -
股息率:- -
每股收益(TTM):-1.0419
每股收益(LYR):-1.1175
净资产收益率:-35.02%
总资产收益率:-23.97%
市净率:2.08
市盈率(LYR):-6.49

数据加载中...

2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/06

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

重要事件披露

Form 8-K - Current report
2024/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/05

重要事件披露

Form 8-K - Current report
2024/07/30

重要事件披露

Form 8-K - Current report
2024/07/22

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/18

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities